Odyssey Therapeutics Rings the Opening Bell
Published on May 8, 2026.
Odyssey.
, a clinical-stage biopharmaceutical company aiming to transform the standard of care for patients with autoimmune and inflammatory diseases. The company's founder and CEO, Gary D.
, attended the ceremony and performed well at the expense of the public.
Related Articles
U.S. economy adds 115,000 jobs in April, while jobless rate holds steady
The US economy added 115,000 jobs in April, while the unemployment rate held steady at 4.3%, reflecting ongoing economic resilience.
US added 115,000 jobs in April, fueling cautious optimism about hiring
U.S. employers added 115,000 jobs in April, boosting hiring optimism despite risks from high oil prices and rising inflation.
Canada's unemployment rate rises to six-month high as full-time jobs drop
Canada's unemployment rate rose to a six-month high in April as full-time job losses hit 46,700, reflecting economic weakness amid trade uncertainty and tariffs.